ClinicalTrials.Veeva

Menu

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

S

San Donato Group (GSD)

Status

Completed

Conditions

Diabetes Mellitus, Type 2

Study type

Observational

Funder types

Other

Identifiers

NCT00520962
199402-1369/516

Details and patient eligibility

About

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.

The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be > 30 years, both gender.

Full description

The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.

Enrollment

1,997 patients

Sex

All

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Fasting glucose levels <126 mg/dl
  • Age >30 years
  • Both male and female

Exclusion criteria

  • Type 1 diabetes
  • Known type 2 diabetes mellitus
  • Pregnancy
  • Impaired kidney and liver function
  • Previous history of malignancies

Trial design

1,997 participants in 2 patient groups

1,2,3
Description:
1. First degree relatives of patients with type 2 diabetes 2. Patients with cardiovascular disease and stroke 3. patients with heart valve disease
4
Description:
Healthy controls

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems